Barclays raises AbbVie target price to $325 from $300
ABBV•Barclays raised its target price for AbbVie to $325 from $300.
Related News
UBS cuts Zoom Communications' target price to $112 from $115
ZM•
Tron Super Representative node rises to No. 1 on TRON network
TRON•
Propanc Biopharma approves 1-for-2 to 1-for-10 reverse stock split
PPCB•
PG&E submits testimony outlining $22.5 billion cost of San Francisco grid takeover
PCG•
NextEra Energy tops quarterly profit estimates, says Dominion deal on track
D•